Intellectual Property, Mergers & Acquisitions, Science, Computers & Technology

Meso Scale Diagnostics, LLC v. Roche Diagnostics GmbH, C.A. No. 5589-VCP (Del. Ch. Feb. 22, 2013) (Parsons, V.C.)

by Potter Anderson & Corroon LLP on 3/6/2013

In this memorandum opinion addressing defendants’ motion for summary judgment, the Court of Chancery dismissed plaintiffs’ claim that a reverse triangular merger constituted an assignment of rights in breach of a contractual...more

Acquiring IT Assets in M&A May Pose Greater Liability Than Value

by Scott & Scott, LLP on 1/15/2013

Robert J. Scott, Managing Partner of Scott & Scott, LLP, says IT assets acquired in a merger may have greater liability attached to them than the assets are worth. Recent cases including Cincom vs. Novelis and ACS vs. Cincom...more

Unfiltered Orange | Weekly eDiscovery News Update – The Second Half of 2012 in Review

by Rob Robinson on 12/31/2012

Highlighted in Forbes’ Law & Technology Blog as one of Eight Great Law & Technology Resources, Orange Legal Technologies’ Unfiltered Orange Weekly eDiscovery News Update provides readers with a trusted compilation of key...more

FTC and DOJ Explore Role of Patent Assertion Entities in the Patent Innovation Market

by John L. Cooper, Stephanie Skaff | Farella Braun + Martel LLP on 12/21/2012

On December 10, 2012, the Federal Trade Commission (FTC) and the Department of Justice (DOJ) jointly presented the “Patent Assertion Entities (PAEs) Activities Workshop.” This publicly-held workshop signaled a recognition by...more

Intellectual Property Bulletin - Fall 2012

by Andrew J. Hall, Mitchell Zimmerman | Fenwick & West LLP on 12/20/2012

In This Issue: - Court Declines to Dish Out Preliminary Injunction in Commercial-Skipping Case Despite Likelihood of Infringement - Free and Open-Source Software Diligence in Mergers, Acquisitions, and...more

Winshall v. Viacom Int'l Inc., C.A. No. 6074-CS (Del. Ch. Dec. 12, 2012) (Strine, C.)

by Potter Anderson & Corroon LLP on 12/19/2012

In this memorandum opinion, the Court of Chancery held that stockholders of an acquired video game developer were not required to indemnify the acquirer for losses it incurred defending claims based on intellectual property...more

Unfiltered Orange | Weekly eDiscovery News Update – November 14, 2012

by Rob Robinson on 11/14/2012

Highlighted in Forbes’ Law & Technology Blog as one of Eight Great Law & Technology Resources, Orange Legal Technologies’ Unfiltered Orange Weekly eDiscovery News Updates provide readers with a trusted compilation of key...more

New FTC/DOJ Position Will Require Heightened Regulatory Reporting of Pharma, Biological and Diagnostic Licenses -- October 25,...

by Loeb & Loeb LLP on 10/3/2012

The Federal Trade Commission and Department of Justice recently announced revisions to the Hart-Scott-Rodino (HSR) Act’s premerger notification rules to require enhanced reporting of transactions (including licenses) relating...more

FTC proposes framework for the transfer of patent rights in the pharmaceutical industry

by Saul Ewing LLP on 10/2/2012

The FTC has proposed amendments to the premerger notification Rules to codify prior FTC guidance concerning when a transaction involving the transfer of rights to a patent in the pharmaceutical and medicine manufacturing...more

FTC Seeks Comments on Proposed HSR Rule Amendments Related to the Transfer of Exclusive Patent Rights in the Pharmaceutical...

by Perkins Coie on 9/10/2012

The Federal Trade Commission (“FTC”) recently announced and asked for comments on proposed changes to the premerger notification rules under the Hart-Scott-Rodino Act (“HSR Act”). The proposed rules would require...more

FTC Sights Set on Pharma Deals – Calls for Additional Hart-Scott-Rodino Reporting

by Proskauer Rose LLP on 8/29/2012

The Federal Trade Commission has proposed expanding Hart-Scott-Rodino reporting and waiting period obligations for certain pharmaceutical, biologics and medicine manufacturing licenses. The new rules are subject to public...more

FTC Flexes Healthcare Regulatory Muscle

by Morgan Lewis on 8/23/2012

Proposed rule includes new requirements for reporting pharmaceutical patent transfers. On August 13, the Federal Trade Commission (FTC) released proposed amendments to the premerger notification rules (the Proposed...more

Yet Another Turn of the Screw: The FTC Again Targets Pharmaceutical Industry, This Time Through the HSR Act

by K&L Gates LLP on 8/21/2012

Fresh from its victory in the Third Circuit on “pay-for-delay” deals involving brand name and generic pharmaceutical companies, the Federal Trade Commission (“FTC”) has announced yet another initiative aimed at the...more

FTC Proposes Amendments to HSR Rules Targeting Certain Pharmaceutical Licensing Arrangements

by Mintz Levin - Antitrust on 8/17/2012

The Federal Trade Commission (FTC) recently announced proposed amendments to the Premerger Notification Rules (HSR Rules) to clarify reporting requirements under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as...more

FTC’s Proposed Rules Would Generate More HSR Filings for Transfers of Pharmaceutical Patent Rights

by McDermott Will & Emery on 8/17/2012

The U.S. Federal Trade Commission’s new proposed Hart-Scott-Rodino Act rules will apply only to transfers of pharmaceutical patent rights and are expected to increase the number of filings. Comments on the proposed rules will...more

FTC Proposes Amendments to the Premerger Notification Rules to Expand the Reportability of Transfers of Exclusive Patent Rights in...

by Sheppard Mullin Richter & Hampton LLP on 8/16/2012

On August 13, 2012, the Federal Trade Commission (“FTC”) proposed amendments to the Premerger Notification Rules issued under the Hart Scott Rodino Antitrust Improvements Act of 1976 (the “HSR Act”). The proposed amendments...more

Home

Legal News

Find a Lawyer

Browse Subjects

Subscribe

Pro Services

For Reporters

Intellectual Property › Mergers & Acquisitions › Science, Computers & Technology

Meso Scale Diagnostics, LLC v. Roche Diagnostics GmbH, C.A. No. 5589-VCP (Del. Ch. Feb. 22, 2013) (Parsons, V.C.)

Acquiring IT Assets in M&A May Pose Greater Liability Than Value

Unfiltered Orange | Weekly eDiscovery News Update – The Second Half of 2012 in Review

FTC and DOJ Explore Role of Patent Assertion Entities in the Patent Innovation Market

Intellectual Property Bulletin - Fall 2012

Winshall v. Viacom Int'l Inc., C.A. No. 6074-CS (Del. Ch. Dec. 12, 2012) (Strine, C.)

Unfiltered Orange | Weekly eDiscovery News Update – November 14, 2012

New FTC/DOJ Position Will Require Heightened Regulatory Reporting of Pharma, Biological and Diagnostic Licenses -- October 25,...

FTC proposes framework for the transfer of patent rights in the pharmaceutical industry

FTC Seeks Comments on Proposed HSR Rule Amendments Related to the Transfer of Exclusive Patent Rights in the Pharmaceutical...

FTC Sights Set on Pharma Deals – Calls for Additional Hart-Scott-Rodino Reporting

FTC Flexes Healthcare Regulatory Muscle

Yet Another Turn of the Screw: The FTC Again Targets Pharmaceutical Industry, This Time Through the HSR Act

FTC Proposes Amendments to HSR Rules Targeting Certain Pharmaceutical Licensing Arrangements

FTC’s Proposed Rules Would Generate More HSR Filings for Transfers of Pharmaceutical Patent Rights

FTC Proposes Amendments to the Premerger Notification Rules to Expand the Reportability of Transfers of Exclusive Patent Rights in...

FTC Proposes New HSR Rules for Exclusive Patent Licenses in the Pharmaceutical Industry

FTC Proposes Changes to HSR Reportability of Patent Licenses

FTC May Expand Premerger Reporting Requirements to Include Pharmaceutical Patent Exclusive Marketing and Sales Licenses

Unfiltered Orange | Weekly eDiscovery News Update – August 8, 2012

Biotech M&A Surges in Advance of Patent Expirations

Managing the IT Transition in Mergers, Acquisitions, and Divestitures

Managing the IT Transition in Mergers, Acquisitions, and Divestitures

Beware of IBM's "Blue Washing"

M&A and Corporate Finance Update, Finland and Nordic Countries

Expand Your Reach